Integral Diagnostics Ltd (IDX) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.074x

Based on the latest financial reports, Integral Diagnostics Ltd (IDX) has a cash flow conversion efficiency ratio of 0.074x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$51.60 Million ≈ $36.51 Million USD) by net assets (AU$693.94 Million ≈ $491.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Integral Diagnostics Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Integral Diagnostics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Integral Diagnostics Ltd (IDX) financial obligations for a breakdown of total debt and financial obligations.

Integral Diagnostics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Integral Diagnostics Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Everbright Jiabao Co Ltd SHG:600622	0.033x
Sable Offshore Corp. NYSE:SOC	-0.318x
Shenzhen Riland Industry Co SHE:300154	0.062x
Genbyte Technology Inc SHE:003028	0.043x
Dian Swastatika Sentosa Tbk JK:DSSA	45.941x
TOMTOM N.V.ADRS 1/2 EO-20 F:OEMB	N/A
Dongjiang Environmental Co Ltd SHE:002672	0.038x
Guangzhou Huayan Precision Machinery Co.Ltd. SHE:301138	0.050x

Annual Cash Flow Conversion Efficiency for Integral Diagnostics Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Integral Diagnostics Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Integral Diagnostics Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$693.94 Million ≈ $491.01 Million	AU$73.77 Million ≈ $52.20 Million	0.106x	-51.52%
2024-06-30	AU$301.71 Million ≈ $213.48 Million	AU$66.16 Million ≈ $46.81 Million	0.219x	+14.54%
2023-06-30	AU$373.05 Million ≈ $263.96 Million	AU$71.42 Million ≈ $50.53 Million	0.191x	+79.19%
2022-06-30	AU$347.24 Million ≈ $245.70 Million	AU$37.10 Million ≈ $26.25 Million	0.107x	-60.88%
2021-06-30	AU$254.74 Million ≈ $180.24 Million	AU$69.57 Million ≈ $49.23 Million	0.273x	+14.95%
2020-06-30	AU$228.33 Million ≈ $161.56 Million	AU$54.25 Million ≈ $38.39 Million	0.238x	-10.90%
2019-06-30	AU$127.22 Million ≈ $90.02 Million	AU$33.92 Million ≈ $24.00 Million	0.267x	-6.06%
2018-06-30	AU$93.42 Million ≈ $66.10 Million	AU$26.52 Million ≈ $18.76 Million	0.284x	+12.83%
2017-06-30	AU$90.35 Million ≈ $63.93 Million	AU$22.73 Million ≈ $16.08 Million	0.252x	-12.23%
2016-06-30	AU$83.92 Million ≈ $59.38 Million	AU$24.05 Million ≈ $17.02 Million	0.287x	-29.91%
2015-06-30	AU$41.84 Million ≈ $29.60 Million	AU$17.11 Million ≈ $12.11 Million	0.409x	-67.85%
2014-06-30	AU$2.90 Million ≈ $2.06 Million	AU$3.70 Million ≈ $2.61 Million	1.272x	-13.56%
2013-06-30	AU$2.54 Million ≈ $1.80 Million	AU$3.74 Million ≈ $2.65 Million	1.472x	+55.94%
2012-06-30	AU$2.54 Million ≈ $1.80 Million	AU$2.40 Million ≈ $1.70 Million	0.944x	--

About Integral Diagnostics Ltd

AU:IDX Australia Diagnostics & Research

Market Cap

$585.79 Million

AU$827.90 Million AUD

Market Cap Rank

#11748 Global

#294 in Australia

Share Price

AU$2.22

Change (1 day)

-0.45%

52-Week Range

AU$2.19 - AU$3.05

All Time High

AU$5.00